Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Perl, S; Stiegler, P; Rotman, B; Prenner, G; Lercher, P; Anelli-Monti, M; Sereinigg, M; Riegelnik, V; Kvas, E; Kos, C; Heinzel, FR; Tscheliessnigg, KH; Pieske, B.
Socio-economic effects and cost saving potential of remote patient monitoring (SAVE-HM trial).
Int J Cardiol. 2013; 169(6):402-407 Doi: 10.1016/j.ijcard.2013.10.019
Web of Science PubMed FullText FullText_MUG


Führende Autor*innen der Med Uni Graz
Perl Sabine
Co-Autor*innen der Med Uni Graz
Anelli-Monti Michael
Heinzel Frank
Kos Cornelia
Lercher Peter
Pieske Burkert Mathias
Prenner Günther
Riegelnik Vesna
Rotman Brigitte
Sereinigg Michael
Stiegler Philipp
Tscheliessnigg Karlheinz

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

In the SAVE-trial we evaluated the safety, reliability and improvements of patient management using the BIOTRONIK Home Monitoring®-System (HM) in pacemaker (PM) and implanted cardioverter defibrillator (ICD) patients. 115 PM (Module A) and 36 ICD-patients (Module B) were recruited 3 months after implantation. 65 patients in Module A were randomised to HM-OFF and had one scheduled outpatient clinic follow-up(FU) per year, whereas patients randomised to HM-ON were equipped with the mobile transmitter and discharged without any further scheduled in-office FU. In Module B 18 patients were randomised to HM-OFF and followed by standard outpatient clinic controls every 6 months; 18 patients were randomised to HM-ON receiving remote monitoring plus one outpatient clinic visit per year; unscheduled follow-ups were performed when necessary. The average follow-up period was 17.1 ± 9.2 months in Module A and 26.3 ± 8.6 months in Module B. In both modules, the number of FUs per year was significantly reduced (Module A HM-ON 0.29 ± 0.6 FUs/year vs HM-OFF 0.53 ± 0.5 FUs/year; p b 0.001; Module B HM-ON 0.87 ± 0.25 vs HM-OFF 1.73 ± 0.53 FU/year,p b 0.001). Cost analysis was significantly lower in the HM-ON group compared to the HM-OFF group (18.0 ± 41.3 and 22.4 ± 26.9 € respectively; p b 0.003). 93% of the unscheduled visits in Module B were clinically indicated,whereas 55% of the routine FUs were classified as clinically unnecessary. Remote home monitoring of pacemaker and ICD devices was safe, reduced overall hospital visits, and detected events that mandated unscheduled visits.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Aged, 80 and over -
Cost Savings - economics
Defibrillators, Implantable - economics
Female -
Follow-Up Studies -
Humans -
Male -
Middle Aged -
Monitoring, Physiologic - economics
Pacemaker, Artificial - economics
Socioeconomic Factors -
Telemedicine - economics

Find related publications in this database (Keywords)
Remote monitoring
© Med Uni Graz Impressum